Neil Collinson
Publications by Year
Research Areas
Vasculitis and related conditions, Coagulation, Bradykinin, Polyphosphates, and Angioedema, Neuroscience and Neuropharmacology Research, Otitis Media and Relapsing Polychondritis, Systemic Lupus Erythematosus Research
Most-Cited Works
- → Trial of Tocilizumab in Giant-Cell Arteritis(2017)1,333 cited
- → Enhanced Learning and Memory and Altered GABAergic Synaptic Transmission in Mice Lacking the α5 Subunit of the GABAAReceptor(2002)621 cited
- → Long-term safety of rituximab in rheumatoid arthritis: 9.5-year follow-up of the global clinical trial programme with a focus on adverse events of interest in RA patients(2012)387 cited
- → α5GABA A Receptors Mediate the Amnestic But Not Sedative-Hypnotic Effects of the General Anesthetic Etomidate(2006)245 cited
- → An Inverse Agonist Selective for α5 Subunit-Containing GABAA Receptors Enhances Cognition(2006)241 cited
- → Loss of the Major GABAAReceptor Subtype in the Brain Is Not Lethal in Mice(2001)232 cited
- → Efficacy and safety of various repeat treatment dosing regimens of rituximab in patients with active rheumatoid arthritis: results of a Phase III randomized study (MIRROR)(2010)183 cited
- → Evidence that the anxiolytic-like effects of chlordiazepoxide on the elevated plus maze are confounded by increases in locomotor activity(1995)175 cited
- → Identification of a Novel, Selective GABAAα5 Receptor Inverse Agonist Which Enhances Cognition(2003)140 cited
- → Anxiogenic properties of an inverse agonist selective for α3 subunit‐containing GABAA receptors(2005)134 cited